2Suppliers
0Customers
3Debt Items
20Related Chains

CalciMedica, Inc. Suppliers

TickerNameConfidenceEvidence
CONTRACT-DEVELOPMENT-AND-MANUFACTURING-ORGANIZAT CONTRACT-DEVELOPMENT-AND-MANUFACTURING-ORGANIZAT 90% The Company has historically entered into contracts in the normal course of business with contract development and manufacturing organizations, for the manufacturing process development and the precl…
VENDORS VENDORS 90% The Company has historically entered into contracts in the normal course of business with contract development and manufacturing organizations, for the manufacturing process development and the precl…

CalciMedica, Inc. Customers

No clients on recordNo downstream customers found in our database for CalciMedica, Inc..

CalciMedica, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
CALC-DEBT-3732 Warrants outstanding: 216000 90% xbrl warrant detail from xbrl 2025-12-31.
CALC-DEBT-3733 Xbrl Convertible 90% xbrl convertible detail from xbrl 2025-12-31.
CALC-DEBT Debt stack $6.7M 90% Market cache reports total debt of $6.7M.

CalciMedica, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for CalciMedica, Inc..

CalciMedica, Inc. Ownership

HolderNameConfidenceEvidence
CALC-OWNER-VANGUARD-GROUP-INC Vanguard Group Inc 95% 13F/ownership overlay lists Vanguard Group Inc; shares held 407,801; ownership 7.20%; value $254,304; as of 2025-12-31.
CALC-OWNER-SOLEUS-CAPITAL-MANAGEMENT-L-P Soleus Capital Management, L.P. 95% 13F/ownership overlay lists Soleus Capital Management, L.P.; shares held 683,904; ownership 12.08%; value $426,482; as of 2025-09-30.
CALC-OWNER-AISLING-CAPITAL-MANAGEMENT-LP Aisling Capital Management LP 95% 13F/ownership overlay lists Aisling Capital Management LP; shares held 521,114; ownership 9.20%; value $324,966; as of 2025-09-30.
CALC-OWNER-GEODE-CAPITAL-MANAGEMENT-LLC Geode Capital Management, LLC 95% 13F/ownership overlay lists Geode Capital Management, LLC; shares held 98,852; ownership 1.75%; value $61,644; as of 2025-09-30.
CALC-OWNER-MERITAGE-PORTFOLIO-MANAGEMENT Meritage Portfolio Management 95% 13F/ownership overlay lists Meritage Portfolio Management; shares held 61,539; ownership 1.09%; value $38,375; as of 2025-12-31.
CALC-OWNER-STONEHAGE-FLEMING-FINANCIAL-SERVICES-HOL Stonehage Fleming Financial Services Holdings Limited 95% 13F/ownership overlay lists Stonehage Fleming Financial Services Holdings Limited; shares held 53,703; ownership 0.95%; value $33,489; as of 2025-12-31.
CALC-OWNER-DEERFIELD-MANAGEMENT-COMPANY-L-P Deerfield Management Company, L.P 95% 13F/ownership overlay lists Deerfield Management Company, L.P; shares held 1,300,000; ownership 22.96%; value $810,680; as of 2025-09-30.
CALC-OWNER-ENVESTNET-ASSET-MANAGEMENT-INC Envestnet Asset Management Inc. 95% 13F/ownership overlay lists Envestnet Asset Management Inc.; shares held 76,705; ownership 1.35%; value $47,833; as of 2025-09-30.
CALC-OWNER-RENAISSANCE-TECHNOLOGIES-LLC Renaissance Technologies, LLC 95% 13F/ownership overlay lists Renaissance Technologies, LLC; shares held 70,000; ownership 1.24%; value $43,652; as of 2025-09-30.
CALC-OWNER-SHEETS-SMITH-INVESTMENT-MANAGEMENT Sheets Smith Investment Management 95% 13F/ownership overlay lists Sheets Smith Investment Management; shares held 51,100; ownership 0.90%; value $31,865; as of 2025-09-30.
CALC-OWNER-VANGUARD-CAPITAL-MANAGEMENT-LLC VANGUARD CAPITAL MANAGEMENT LLC 90% 13F overlay lists VANGUARD CAPITAL MANAGEMENT LLC as top holder; 30 tracked holders.

CalciMedica, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
DBVTF DBV TECHNOLOGIES 100.00 2
BNTC Benitec Biopharma Inc. 100.00 2
WHWK Whitehawk Therapeutics, Inc. 100.00 2
BLRX BioLineRx Ltd. 100.00 2
ALXO ALX Oncology Holdings Inc. 100.00 2
ATOS Atossa Therapeutics, Inc. 100.00 2
BNBX BNB Plus Corp. 100.00 2
CYTOF Altamira Therapeutics Ltd. 100.00 2
CTMX CytomX Therapeutics, Inc. 100.00 2
CYTK Cytokinetics, Incorporated 100.00 2
CBIO Crescent Biopharma, Inc. 100.00 2
ANL Adlai Nortye Ltd. 100.00 2
ANRO Alto Neuroscience, Inc. 100.00 2
EDIT Editas Medicine, Inc. 100.00 2
CCEP Coca-Cola Europacific Partners PLC 100.00 2
DSGN Design Therapeutics, Inc. 100.00 2
PSNL Personalis, Inc. 100.00 2
AZN AstraZeneca PLC 100.00 2
BIOA BioAge Labs, Inc. 100.00 2
REGN Regeneron Pharmaceuticals, Inc. 100.00 2